Aeva Technologies, Inc. (AEVA) came out with a quarterly loss of $0.4 per share versus the Zacks Consensus Estimate of a loss of $0.44. This compares to a loss of $0.49 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +9.09%. A quarter ago, it was expected that this company would post a loss of $0.45 per share when it actually produced a loss of $0.46, delivering a surprise of -2.22%.Over the last four quarters, the company has ...

Aeva Technologies (NYSE:AEVA) Q4 2025 Earnings call February 26, 2026 05:00 PM ET Company ParticipantsAndrew Fung - Senior Director of Investor Relations and Corporate DevelopmentColin Rusch - Managing Director and Head of Sustainable Growth and Resource Optimization ResearchJoe Moore - Managing DirectorMatthew Paciulli - Equity Research AssociateSaurabh Sinha - CFOSoroush Salehian - Co-Founder and CEOConference Call ParticipantsRichard Shannon - Senior Research AnalystSuji Desilva - Managing Director and S ...

Aeva Technologies (NYSE:AEVA) Q4 2025 Earnings call February 26, 2026 05:00 PM ET Company ParticipantsAndrew Fung - Senior Director of Investor Relations and Corporate DevelopmentColin Rusch - Managing Director and Head of Sustainable Growth and Resource Optimization ResearchJoe Moore - Managing DirectorMatthew Paciulli - Equity Research AssociateSaurabh Sinha - CFOSoroush Salehian - Co-Founder and CEOConference Call ParticipantsRichard Shannon - Senior Research AnalystSuji Desilva - Managing Director and S ...

Aeva Technologies (NYSE:AEVA) Q4 2025 Earnings call February 26, 2026 05:00 PM ET Speaker7Good day. My name is Stephanie, and I will be your conference facilitator. I would like to welcome everyone to Aeva Technologies' 4th quarter and full year 2025 earnings conference call. During opening remarks, all participants will be in a listen-only mode. Following the opening remarks, we will conduct a question-and-answer session. As a reminder, today's conference is being recorded and simultaneously webcast. I wou ...

Fourth Quarter and Full Year 2025 Results © 2026 Aeva, Inc. Legal Disclaimer Forward-looking Statements This presentation contains certain forward-looking statements within the meaning of the federal securities laws. Forward-looking statements generally are identified by the words "believe," "project," "expect," "anticipate," "estimate," "intend," "strategy," "future," "opportunity," "plan," "may," "should," "will," "would," "will be," "will continue," "will likely result," and similar expressions. These fo ...

Exhibit 99.1 Aeva Reports Fourth Quarter and Full Year 2025 Results 2026 Financial Outlook • Revenue in the range of $30 million to $36 million, representing growth of approximately 70% to 100% year-over-year Awarded Major Global Production Contract from Top 10 Passenger OEM Selected by Top 5 Passenger OEM for Global Vehicle Development Program Nvidia Selected Aeva as Reference LiDAR Sensor for DRIVE Hyperion Platform Doubled Revenue in 2025 Driven by Scaling Volume and New Markets Expansion MOUNTAIN VIEW, ...

Core Insights - The article highlights the top-performing analysts in the U.S. for the year 2025, as ranked by TipRanks based on their success rates and average returns [1][2]. Analyst Rankings - **Sam Slutsky – LifeSci Capital**: Achieved the highest ranking with a success rate of 67.74% and an average return of 62.4%. His notable recommendation on Abivax SA (ABVX) yielded a return of 894.81% [3]. - **Richard Shannon – Craig-Hallum**: Ranked second with a success rate of 61.87% and an average return of 36.9%. His top call on Aeva Technologies (AEVA) generated a return of 822.14% [4]. - **Joseph Stringer – Needham**: Secured the third position with a success rate of 79.17% and an average return of 38.2%. His best recommendation was for Inozyme Pharma (INZY), which returned 361.9% [5]. - **Myles Minter – William Blair**: Fourth place with a success rate of 66.93% and an average return of 28.8%. His top recommendation on Ovid Therapeutics (OVID) yielded a profit of 350% [6]. - **Ruben Roy – Stifel Nicolaus**: Fifth on the list with a success rate of 75.68% and an average return of 35.3%. His best call on CoreWeave (CRWV) generated a return of 293.2% [7]. - **Seamus Fernandez – Guggenheim**: Ranked sixth with a success rate of 78.57% and an average return of 40.6%. His best recommendation was for Cidara Therapeutics (CDTX), which returned 244.7% [8]. - **Thomas Smith – Leerink Partners**: Seventh place with an average return of 30.7% and a success rate of 65.22%. His best recommendation on Abivax yielded a return of 880.34% [9]. - **Mark Miller – Benchmark Co.**: Eighth with a success rate of 59.8% and an average return of 11.1%. His top call on SanDisk (SNDK) generated a return of 470.6% [11]. - **Allison Bratzel – Piper Sandler**: Ninth position with a success rate of 63.64% and an average return of 58.2%. His recommendation for Abivax also yielded a return of 894.81% [12]. - **Julian Harrison – BTIG**: Tenth with a success rate of 59.38% and an average return of 37%. His top recommendation on Abivax generated a return of 1,057.12% [13].

Market Overview - U.S. stock futures are lower, with Dow futures dropping approximately 700 points [1] Company-Specific Developments - Valneva SE has withdrawn its IXCHIQ Chikungunya vaccine BLA and IND in the U.S. following an FDA suspension and a review of new serious adverse events, leading to a 7.7% decline in shares to $9.29 in pre-market trading [1] - Rezolve AI PLC shares fell 15% to $3.92 in pre-market trading [2] - POET Technologies Inc experienced an 11.2% decline to $7.37 in pre-market trading [2] - Forward Industries Inc shares decreased by 10.5% to $7.70 after a previous gain of 4% on Friday [2] - Babcock & Wilcox Enterprises Inc shares dipped 9.9% to $7.59 in pre-market trading [2] - Bakkt Holdings Inc fell 9.5% to $19.38 after a 10% increase on Friday [2] - Applovin Corp shares decreased by 9.5% to $515.03 after a 6% decline on Friday [2] - ALT5 Sigma Corp shares fell 8.9% to $2.36 after gaining 7% on Friday, despite regaining Nasdaq compliance [2] - HIVE Digital Technologies Ltd shares dropped 7.7% to $3.20 in pre-market trading [2] - Aeva Technologies Inc shares declined 6.8% to $18.01 in pre-market trading [2] - Bitdeer Technologies Group fell 6.8% to $14.75 in pre-market trading [2] - Terrestrial Energy Inc shares decreased by 6.3% to $10.95 in pre-market trading [2] - Tesla Inc shares fell 2.7% to $425.75, with CEO Elon Musk confirming that vehicles equipped with the AI4 (HW4) chip will achieve unsupervised autonomous driving without upgrades [2] - NVIDIA Corp shares declined 2.4% to $181.77 in pre-market trading [2]

Core Insights - Aeva Technologies, Inc. is a leader in advanced sensing and perception systems for autonomous vehicles, with its 4D LiDAR technology setting new industry standards [1] - The company is facing challenges in profitability and cash flow generation, indicated by a negative P/E ratio and earnings yield [3][4] Financial Performance - Aeva has a negative price-to-earnings (P/E) ratio of -7.10 and an earnings yield of -14.09%, highlighting its struggle to achieve profitability [3] - The company maintains a strong liquidity position with a current ratio of 3.18, indicating it can meet short-term liabilities [3] - Valuation metrics show a price-to-sales ratio of 72.60 and an enterprise value to sales ratio of 69.99, reflecting high investor expectations for future growth [3] - The enterprise value to operating cash flow ratio stands at -9.32, indicating difficulties in generating positive cash flow [3] Recent Transactions - On January 15, 2026, the CFO of Aeva, Sinha Saurabh, sold 31,600 shares at approximately $20.98 each, following a previous sale of 20,609 shares at $18.85 on January 9, totaling around $388,480 [2] - Despite these sales, Saurabh retains a significant ownership stake with 629,456 shares remaining [2] Market Position - Aeva operates in a highly competitive market but continues to innovate and develop technology, which may provide optimism for its future prospects [1][4]

Core Insights - Aeva Technologies, a LiDAR-on-chip innovator, reported a significant insider sale by CEO Soroush Salehian Dardashti, who sold 488,160 shares for approximately $6.3 million on January 2, 2026 [1][4] - The sale represents Dardashti's largest single direct sale to date, exceeding his historical median sell size and indicating a high cadence of selling activity [7] Transaction Summary - Shares sold directly: 488,160 [2] - Total transaction value: $6.3 million [2] - Post-transaction direct shares: 1,831,199 [2] - Post-transaction indirect shares: 1,884,808 [2] - Post-transaction value of direct ownership: approximately $23.35 million [2] Company Overview - Aeva Technologies reported a trailing twelve months (TTM) revenue of $15.15 million and a net income loss of $156.26 million [5] - The stock price as of January 2, 2026, was $12.96, with a one-year price change of 342.54% [5] Company Snapshot - Aeva develops 4D LiDAR-on-chip products utilizing frequency modulated continuous wave (FMCW) sensing technology, serving various applications including automated driving and consumer electronics [6][8] Market Impact - Following Dardashti's sale, Aeva's stock price increased significantly, attributed to a deal with Nvidia for integrating Aeva's technology into the NVIDIA DRIVE Hyperion autonomous vehicle platform [11][12] - The stock price rose by 56% since the sale date, indicating strong market performance [9] Ownership Changes - Dardashti's sale reduced his direct holdings from 2,319,359 to 1,831,199 shares, while his indirect holdings remained unchanged [7] - The sale reflects a narrowing pool of shares available for future dispositions, as Dardashti's total holdings have declined by 64.88% since March 2025 [4]